Atria Wealth Solutions Inc. Decreases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Atria Wealth Solutions Inc. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 12.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 46,153 shares of the healthcare conglomerate’s stock after selling 6,425 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in UnitedHealth Group were worth $24,299,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Magnolia Capital Advisors LLC grew its stake in shares of UnitedHealth Group by 24.2% during the 4th quarter. Magnolia Capital Advisors LLC now owns 2,087 shares of the healthcare conglomerate’s stock valued at $1,051,000 after purchasing an additional 406 shares during the period. Capital Advisors Ltd. LLC grew its stake in shares of UnitedHealth Group by 3.7% during the 4th quarter. Capital Advisors Ltd. LLC now owns 1,722 shares of the healthcare conglomerate’s stock valued at $907,000 after acquiring an additional 62 shares during the period. Carret Asset Management LLC lifted its holdings in UnitedHealth Group by 0.8% in the 4th quarter. Carret Asset Management LLC now owns 6,586 shares of the healthcare conglomerate’s stock worth $3,467,000 after purchasing an additional 51 shares in the last quarter. Alaska Permanent Fund Corp purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $4,242,000. Finally, Cumberland Partners Ltd raised its holdings in shares of UnitedHealth Group by 11.3% during the 4th quarter. Cumberland Partners Ltd now owns 71,607 shares of the healthcare conglomerate’s stock worth $36,484,000 after acquiring an additional 7,263 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

UNH stock traded up $1.12 during trading on Wednesday, hitting $487.30. 3,722,296 shares of the company traded hands, compared to its average volume of 4,532,990. The stock’s 50-day simple moving average is $486.90 and its 200 day simple moving average is $514.57. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company has a market cap of $449.26 billion, a PE ratio of 29.79, a P/E/G ratio of 1.42 and a beta of 0.54. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period last year, the business earned $6.26 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.54%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

Analyst Ratings Changes

Several analysts have recently issued reports on UNH shares. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Royal Bank of Canada decreased their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. TD Cowen decreased their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 10th. Finally, Bank of America reaffirmed a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.